Schonfeld Strategic Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Schonfeld Strategic Advisors’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,500	Closed	-$476K	–	2503
2023 Q4	$476K	Buy	+2,500	New	+$472K	﹤0.01%	1301

Other funds holding SWAV

Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

UWS

Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Schonfeld Strategic Advisors's SWAV Position: Q2 2024 in Review

Schonfeld Strategic Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 4,597 shares — an estimated $1.5M sold.

Schonfeld Strategic Advisors first reported a position in SWAV in Q2 2020 and held it in 11 quarters. The position peaked at $6.12M in Q4 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

Schonfeld Strategic Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Schonfeld Strategic Advisors sold 4,597 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $1.5M.
Schonfeld Strategic Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2020 and held it in 11 quarters.
Schonfeld Strategic Advisors's Shockwave Medical, Inc. Common Stock position peaked at $6.12M in Q4 2023.
7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.